A detailed history of Qvt Financial LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Qvt Financial LP holds 65,793,779 shares of ROIV stock, worth $788 Million. This represents 73.2% of its overall portfolio holdings.

Number of Shares
65,793,779
Previous 66,719,779 1.39%
Holding current value
$788 Million
Previous $705 Million 7.66%
% of portfolio
73.2%
Previous 72.99%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.17 - $12.5 $9.42 Million - $11.6 Million
-926,000 Reduced 1.39%
65,793,779 $759 Million
Q1 2024

May 15, 2024

SELL
$9.87 - $11.8 $452 Million - $541 Million
-45,821,757 Reduced 40.72%
66,719,779 $703 Million
Q3 2023

Nov 14, 2023

SELL
$9.76 - $13.19 $97.6 Million - $132 Million
-10,000,000 Reduced 8.16%
112,541,536 $1.31 Billion
Q4 2022

Feb 14, 2023

SELL
$3.36 - $7.99 $23 Million - $54.7 Million
-6,852,281 Reduced 5.3%
122,541,536 $979 Million
Q4 2021

Feb 14, 2022

BUY
$5.86 - $13.52 $758 Million - $1.75 Billion
129,393,817 New
129,393,817 $1.3 Billion

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.43B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Qvt Financial LP Portfolio

Follow Qvt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qvt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Qvt Financial LP with notifications on news.